Stay updated on Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial

Sign up to get notified when there's something new on the Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A site-wide NIH notice was added, announcing that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and linking to updates and FAQs.
    Difference
    0.8%
    Check dated 2026-10-25T01:27:21.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer's site revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T01:11:56.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T01:44:41.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    A new revision entry (v3.7.0) was added to the history, and the previous revision (v3.6.6) was removed from the list.
    Difference
    0.1%
    Check dated 2026-09-20T00:30:26.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The study record history now shows a new revision entry, v3.6.6, and removes the previous v3.6.5 entry. This update reflects a change in the page's versioning metadata rather than substantive trial content.
    Difference
    0.1%
    Check dated 2026-08-29T20:00:11.000Z thumbnail image
  6. Check
    80 days ago
    Change Detected
    Summary
    The study record history now reflects a new revision entry (v3.6.5) and removes the previous revision (v3.6.4), signaling an update to the version history rather than changes to study data.
    Difference
    0.1%
    Check dated 2026-08-08T17:07:26.000Z thumbnail image

Stay in the know with updates to Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial page.